Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-

Infliximab Product Approval Information - Licensing Action

Proper name: Infliximab
Tradename: Remicade
Manufacturer: Centocor, Inc, Malvern, PA, License #1242
Indication for Use: Improving physical function in patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to methotrexate
Approval Date: 2/27/2002
Type of submission: Biologics license application

 

Approval Letter - (PDF)

Label - (PDF)

-
-